Jayda Greco will be speaking at GLP-1 Law and Policy to address the expanding role of GLP-1 therapies beyond diabetes and obesity. She will cover regulatory and market challenges, FDA/EMA approvals, scientific support for new uses, and how virtual care and personalized medicine can enhance access.